BRPI0913913A2 - regime de dosagem para nitrocatecóis - Google Patents
regime de dosagem para nitrocatecóisInfo
- Publication number
- BRPI0913913A2 BRPI0913913A2 BRPI0913913A BRPI0913913A BRPI0913913A2 BR PI0913913 A2 BRPI0913913 A2 BR PI0913913A2 BR PI0913913 A BRPI0913913 A BR PI0913913A BR PI0913913 A BRPI0913913 A BR PI0913913A BR PI0913913 A2 BRPI0913913 A2 BR PI0913913A2
- Authority
- BR
- Brazil
- Prior art keywords
- nitrocathecols
- dosing regimen
- regimen
- dosing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13724808P | 2008-07-29 | 2008-07-29 | |
| PCT/PT2009/000044 WO2010014025A1 (en) | 2008-07-29 | 2009-07-29 | Administration regime for nitrocatechols |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0913913A2 true BRPI0913913A2 (pt) | 2015-10-13 |
Family
ID=41130570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0913913A BRPI0913913A2 (pt) | 2008-07-29 | 2009-07-29 | regime de dosagem para nitrocatecóis |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20110301204A1 (pt) |
| EP (1) | EP2307020B1 (pt) |
| JP (2) | JP6165412B2 (pt) |
| KR (3) | KR20110044949A (pt) |
| CN (1) | CN102355900A (pt) |
| AR (1) | AR072846A1 (pt) |
| AU (1) | AU2009277196B2 (pt) |
| BR (1) | BRPI0913913A2 (pt) |
| CA (1) | CA2729288C (pt) |
| DK (1) | DK2307020T3 (pt) |
| ES (1) | ES2723729T3 (pt) |
| IL (1) | IL210393A0 (pt) |
| MX (2) | MX2011001046A (pt) |
| PT (1) | PT2307020T (pt) |
| RU (1) | RU2557532C2 (pt) |
| TR (1) | TR201906117T4 (pt) |
| WO (1) | WO2010014025A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ565460A (en) | 2005-07-26 | 2011-06-30 | Bial Portela & Ca Sa | Nitrocatechol derivatives as COMT inhibitors |
| EP1845097A1 (en) | 2006-04-10 | 2007-10-17 | Portela & Ca., S.A. | Oxadiazole derivatives as COMT inhibitors |
| US8524746B2 (en) | 2007-01-31 | 2013-09-03 | Bial-Portela & Ca., S.A. | Dosage regimen for COMT inhibitors |
| AR070907A1 (es) | 2008-03-17 | 2010-05-12 | Bial Portela & Ca Sa | Formas cristalinas de derivado de nitrocatecol |
| ES2730678T3 (es) | 2009-04-01 | 2019-11-12 | Bial Portela & Ca Sa | Formulaciones farmacéuticas que comprenden derivados de nitrocatecol y métodos para fabricarlas |
| KR20120092175A (ko) * | 2009-12-04 | 2012-08-20 | 죤 이. 그랜트 | 카테콜-0-메틸-트랜스퍼라제 저해제를 사용한 충동 제어 장애의 치료 |
| US20140045900A1 (en) * | 2011-02-11 | 2014-02-13 | Bial-Portela & Ca, S.A. | Administration regime for nitrocatechols |
| HUE047856T2 (hu) | 2011-12-13 | 2020-05-28 | Bial Portela & Ca Sa | Kémiai vegyület, amely köztitermékként használható katechol-O-metil-transzferáz inhibitor elõállításához |
| WO2016083863A1 (en) | 2014-11-28 | 2016-06-02 | Bial - Portela & Ca, S.A. | Medicaments for slowing parkinson's disease |
| EP3860603A1 (en) | 2018-10-05 | 2021-08-11 | Neurocrine Biosciences, Inc. | Methods for the administration of comt inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10338174A1 (de) * | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit |
| US20060173074A1 (en) * | 2004-11-10 | 2006-08-03 | Juha Ellmen | Treatment of restless legs syndrome |
| EA015813B1 (ru) * | 2005-05-18 | 2011-12-30 | Аддекс Фарма Са | Замещенные производные оксадиазола в качестве положительных аллостерических модуляторов метаботропных глутаматных рецепторов |
| NZ565460A (en) * | 2005-07-26 | 2011-06-30 | Bial Portela & Ca Sa | Nitrocatechol derivatives as COMT inhibitors |
| EP1845097A1 (en) * | 2006-04-10 | 2007-10-17 | Portela & Ca., S.A. | Oxadiazole derivatives as COMT inhibitors |
| US8524746B2 (en) * | 2007-01-31 | 2013-09-03 | Bial-Portela & Ca., S.A. | Dosage regimen for COMT inhibitors |
| AR070907A1 (es) * | 2008-03-17 | 2010-05-12 | Bial Portela & Ca Sa | Formas cristalinas de derivado de nitrocatecol |
-
2009
- 2009-07-29 MX MX2011001046A patent/MX2011001046A/es not_active Application Discontinuation
- 2009-07-29 KR KR1020107029508A patent/KR20110044949A/ko active Search and Examination
- 2009-07-29 BR BRPI0913913A patent/BRPI0913913A2/pt not_active Application Discontinuation
- 2009-07-29 US US13/002,287 patent/US20110301204A1/en not_active Abandoned
- 2009-07-29 CN CN2009801261379A patent/CN102355900A/zh active Pending
- 2009-07-29 AR ARP090102886A patent/AR072846A1/es unknown
- 2009-07-29 PT PT09788437T patent/PT2307020T/pt unknown
- 2009-07-29 ES ES09788437T patent/ES2723729T3/es active Active
- 2009-07-29 TR TR2019/06117T patent/TR201906117T4/tr unknown
- 2009-07-29 KR KR1020187023723A patent/KR20180095135A/ko not_active Application Discontinuation
- 2009-07-29 JP JP2011521064A patent/JP6165412B2/ja active Active
- 2009-07-29 DK DK09788437.3T patent/DK2307020T3/da active
- 2009-07-29 MX MX2015018058A patent/MX360330B/es unknown
- 2009-07-29 KR KR1020197018533A patent/KR20190079705A/ko not_active IP Right Cessation
- 2009-07-29 WO PCT/PT2009/000044 patent/WO2010014025A1/en active Application Filing
- 2009-07-29 RU RU2010154173/15A patent/RU2557532C2/ru active
- 2009-07-29 AU AU2009277196A patent/AU2009277196B2/en not_active Ceased
- 2009-07-29 EP EP09788437.3A patent/EP2307020B1/en active Active
- 2009-07-29 CA CA2729288A patent/CA2729288C/en active Active
-
2010
- 2010-12-30 IL IL210393A patent/IL210393A0/en unknown
-
2015
- 2015-02-26 JP JP2015036568A patent/JP6518080B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2723729T3 (es) | 2019-08-30 |
| KR20190079705A (ko) | 2019-07-05 |
| KR20110044949A (ko) | 2011-05-03 |
| RU2010154173A (ru) | 2012-09-10 |
| KR20180095135A (ko) | 2018-08-24 |
| JP6518080B2 (ja) | 2019-05-22 |
| AU2009277196B2 (en) | 2015-06-18 |
| AR072846A1 (es) | 2010-09-22 |
| CN102355900A (zh) | 2012-02-15 |
| AU2009277196A1 (en) | 2010-02-04 |
| EP2307020B1 (en) | 2019-02-20 |
| DK2307020T3 (da) | 2019-05-13 |
| CA2729288C (en) | 2017-01-17 |
| TR201906117T4 (tr) | 2019-05-21 |
| WO2010014025A1 (en) | 2010-02-04 |
| JP6165412B2 (ja) | 2017-07-19 |
| IL210393A0 (en) | 2011-03-31 |
| US20110301204A1 (en) | 2011-12-08 |
| PT2307020T (pt) | 2019-05-28 |
| JP2015129163A (ja) | 2015-07-16 |
| JP2011529489A (ja) | 2011-12-08 |
| MX360330B (es) | 2018-10-30 |
| RU2557532C2 (ru) | 2015-07-20 |
| CA2729288A1 (en) | 2010-02-04 |
| EP2307020A1 (en) | 2011-04-13 |
| MX2011001046A (es) | 2011-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0913913A2 (pt) | regime de dosagem para nitrocatecóis | |
| BRPI0919548A2 (pt) | pacote para inserto | |
| BRPI0905083A2 (pt) | Embalagem para alimentos prontos | |
| BRPI0913377A2 (pt) | regime de dosagem | |
| DK2200752T3 (da) | Doseringsindretning | |
| BRPI0913873A2 (pt) | recipiente para dose única | |
| DK2272763T3 (da) | Blisterpakning-dispensermaskine | |
| DK2342060T3 (da) | Doseringsindretning | |
| BRPI0923891A2 (pt) | dispositivo de dosagem | |
| BRPI1011446A2 (pt) | unidade de dosagem para cip/sipit | |
| DE602008002548D1 (de) | Verpackungsanordnung | |
| ES1069245Y (es) | Estuche para envases de medicamentos homeopaticos | |
| ES1067523Y (es) | Tarima para alcorques | |
| AT506763A3 (de) | Tragebehälter | |
| ES1068685Y (es) | Mecanismo para blister | |
| TH101459B (th) | สิ่งบรรจุเพื่อการหีบห่อ | |
| UA18024S (uk) | Упаковка для фіточаю | |
| ES1066520Y (es) | Envase para objetos | |
| FI8316U1 (fi) | Annostin | |
| UA17111S (uk) | Дозуючий пристрій | |
| ES1065542Y (es) | Dosificador para gas licuado | |
| ES1068853Y (es) | Bandeja para tableta de turron | |
| BRPI0920534A2 (pt) | conjunto transportador | |
| ES1068185Y (es) | Estuche para dispositivos multimedia | |
| UY3908Q (es) | Envase para golosina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |